MannKind's Future: More than Just Afrezza?
MannKind's pipeline of opportunity is explored.
MannKind Corporation: Past, Present, and Future
Let's learn about the history and future prospects of MannKind as it launches its first drug, Afrezza.
10 Most Hated Companies in Healthcare
When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.
3 Questions to Ask Before You Buy a Biotech Stock
One Motley Fool analyst explains the key questions investors should answer before buying biotech stocks.
Pain-Free Blood Tests? Sign Me Up!
A small, Wisconsin-based company could be on the verge of developing a revolutionary new blood test that is virtually pain-free. Find out how personalized healthcare is transforming the medical field.